Determining the specificity of HLA antibodies is arguably one of the most important contributions by the HLA laboratory today. For patients that have low-to-moderate levels of antibody, using a ...

The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, growing at a CAGR of 12.23%. This growth is fueled by advancements in ...

Beacon Discovery™ enables real-time functional investigation of single cells. Powered by optofluidic technology, it allows researchers to investigate multimodal and temporal cellular responses in real ...

The global antibody testing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% between ...

Identifying low-abundance monoclonal antibodies within a population of polyclonal antibodies provides insights for various applications, including understanding disease mechanisms, vaccine development ...

A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the role of B cells and self-reactive antibodies in lupus, systemic sclerosis, ...

Expert Rev Clin Immunol. 2008;4(3):391-399. New, solid-phase technologies for HLA antibody screening and identification have emerged that are more sensitive and more specific than previous testing ...